Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma

NCT05324384 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hemangioendothelioma

Interventions

DRUG: Sirolimus

Sponsor

West China Hospital